“RECIPIENT-TO-DONOR ANTI-CMV IGG RATIO AS A PREDICTOR OF CMV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE-CONTROL STUDY”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026078, Oct. 2026, doi: 10.4084/MJHID.2026.078.